CARMINE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, July 1, 2020, a trademark application was filed for CARMINE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CARMINE THERAPEUTICS trademark a serial number of 79292145. The federal status of this trademark filing is REGISTERED as of Tuesday, September 13, 2022. This trademark is owned by Carmine Therapeutics Pte. Ltd.. The CARMINE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations, namely, red blood cells comprising of extracellular vesicles for therapeutic medical applications; biological preparations, namely, red blood cells comprising of extracellular vesicles containing nucleic acids for medical gene therapy

Scientific and medical research; biopharmaceutical research and development of new pharmaceutical medicines based on gene therapy; pharmaceutical research and development of new pharmaceutical medicines based on gene therapy; product development for others in the field of biotechnology
carmine therapeutics

General Information

Serial Number79292145
Word MarkCARMINE THERAPEUTICS
Filing DateWednesday, July 1, 2020
Status700 - REGISTERED
Status DateTuesday, September 13, 2022
Registration Number6841265
Registration DateTuesday, September 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesBiological preparations, namely, red blood cells comprising of extracellular vesicles for therapeutic medical applications; biological preparations, namely, red blood cells comprising of extracellular vesicles containing nucleic acids for medical gene therapy
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific and medical research; biopharmaceutical research and development of new pharmaceutical medicines based on gene therapy; pharmaceutical research and development of new pharmaceutical medicines based on gene therapy; product development for others in the field of biotechnology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCarmine Therapeutics Pte. Ltd.
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressSG
Party NameCarmine Therapeutics Pte. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressSG
Party NameCarmine Therapeutics Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 14, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 13, 2022FINAL DISPOSITION PROCESSED
Tuesday, December 13, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 13, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 5, 2022NOTIFICATION PROCESSED BY IB
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 8, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2022ASSIGNED TO LIE
Monday, May 9, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, February 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, December 3, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 3, 2021LETTER OF SUSPENSION E-MAILED
Friday, December 3, 2021SUSPENSION LETTER WRITTEN
Wednesday, December 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 1, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 2, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 2, 2021FINAL REFUSAL E-MAILED
Wednesday, June 2, 2021FINAL REFUSAL WRITTEN
Tuesday, May 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 21, 2020REFUSAL PROCESSED BY IB
Thursday, November 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 5, 2020REFUSAL PROCESSED BY MPU
Thursday, October 15, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 14, 2020NON-FINAL ACTION WRITTEN
Wednesday, October 7, 2020ASSIGNED TO EXAMINER
Tuesday, August 25, 2020APPLICATION FILING RECEIPT MAILED
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 20, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

therapeutics carmine gene therapy research development pharmaceutical medical extracellular biological cells blood